Advertisement
Loading...

Ecograf Ltd

FMK.HMHAM
Basic Materials
Other Precious Metals
0.19
0.001(0.42%)
German Market opens in 2h 46m

Ecograf Ltd Fundamental Analysis

Ecograf Ltd (FMK.HM) shows weak financial fundamentals with a PE ratio of -37.26, profit margin of 0.00%, and ROE of -8.01%. The company generates N/A in annual revenue with weak year-over-year growth of 0.00%.

Key Strengths

Current Ratio4.57

Areas of Concern

ROE-8.01%
Operating Margin0.00%
PEG Ratio26.85
We analyze FMK.HM's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 22.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
22.0/100

We analyze FMK.HM's fundamental strength across five key dimensions:

Efficiency Score

Weak

FMK.HM struggles to generate sufficient returns from assets.

ROA > 10%
-7.59%

Valuation Score

Moderate

FMK.HM shows balanced valuation metrics.

PE < 25
-37.26
PEG Ratio < 2
26.85

Growth Score

Moderate

FMK.HM shows steady but slowing expansion.

Revenue Growth > 5%
0.00%
EPS Growth > 10%
12.00%

Financial Health Score

Excellent

FMK.HM maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
4.57

Profitability Score

Weak

FMK.HM struggles to sustain strong margins.

ROE > 15%
-800.73%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is FMK.HM Expensive or Cheap?

P/E Ratio

FMK.HM trades at -37.26 times earnings. This suggests potential undervaluation.

-37.26

PEG Ratio

When adjusting for growth, FMK.HM's PEG of 26.85 indicates potential overvaluation.

26.85

Price to Book

The market values Ecograf Ltd at 2.93 times its book value. This may indicate undervaluation.

2.93

EV/EBITDA

Enterprise value stands at -23.48 times EBITDA. This is generally considered low.

-23.48

How Well Does FMK.HM Make Money?

Net Profit Margin

For every $100 in sales, Ecograf Ltd keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $-8.01 in profit for every $100 of shareholder equity.

-8.01%

ROA

Ecograf Ltd generates $-7.59 in profit for every $100 in assets, demonstrating efficient asset deployment.

-7.59%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.00 in free cash annually.

$-0.00

FCF Yield

FMK.HM converts -0.54% of its market value into free cash.

-0.54%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-37.26

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

26.85

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.93

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.002

vs 25 benchmark

Current Ratio

Current assets to current liabilities

4.57

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.08

vs 25 benchmark

ROA

Return on assets percentage

-0.08

vs 25 benchmark

ROCE

Return on capital employed

-0.14

vs 25 benchmark

How FMK.HM Stacks Against Its Sector Peers

MetricFMK.HM ValueSector AveragePerformance
P/E Ratio-37.2624.86 Better (Cheaper)
ROE-8.01%943.00% Weak
Net Margin0.00%-105015.00% (disorted) Weak
Debt/Equity0.000.53 Strong (Low Leverage)
Current Ratio4.576.81 Strong Liquidity
ROA-7.59%-6938.00% (disorted) Weak

FMK.HM outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Ecograf Ltd's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Cyclical, Commodity, Value

Declining

EPS CAGR

-21.50%

Industry Style: Cyclical, Commodity, Value

Declining

FCF CAGR

-50.27%

Industry Style: Cyclical, Commodity, Value

Declining

Fundamental Analysis FAQ